Hallmarks of Cancer: New Dimensions
Open accessThe DOI matches its Crossref record; 127 of the 129 references it cites were found in a registry or an index.
Abstract
The hallmarks of cancer conceptualization is a heuristic tool for distilling the vast complexity of cancer phenotypes and genotypes into a provisional set of underlying principles. As knowledge of cancer mechanisms has progressed, other facets of the disease have emerged as potential refinements. Herein, the prospect is raised that phenotypic plasticity and disrupted differentiation is a discrete hallmark capability, and that nonmutational epigenetic reprogramming and polymorphic microbiomes both constitute distinctive enabling characteristics that facilitate the acquisition of hallmark capabilities. Additionally, senescent cells, of varying origins, may be added to the roster of functionally important cell types in the tumor microenvironment. Significance: Cancer is daunting in the breadth and scope of its diversity, spanning genetics, cell and tissue biology, pathology, and response to therapy. Ever more powerful experimental and computational tools and technologies are providing an avalanche of “big data” about the myriad manifestations of the diseases that cancer encompasses. The integrative concept embodied in the hallmarks of cancer is helping to distill this complexity into an increasingly logical science, and the provisional new dimensions presented in this perspective may add value to that endeavor, to more fully understand mechanisms of cancer development and malignant progression, and apply that knowledge to cancer medicine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Therefore, cellular senescence is now considered one of the hallmarks of cancer (3).”
From Chromatin conformational changes at human satellite II contribute to the senescence phenotype in the tumor microenvironment (2023) · cites this paper as [3]
In the citing paper
“Initially proposed by Hanahan and Weinberg in 2000, this concept has since been expanded to encompass 14 distinct hallmarks of cancer.67,68”
From Drug repurposing for cancer therapy (2024) · cites this paper as [67]
In the citing paper
“The hallmarks of cancer are fundamental characteristics that drive the development and progression of cancer.”
From Drug repurposing for cancer therapy (2024) · cites this paper as [67]
In the citing paper
“Such findings are frequently reported in bulk tumor transcriptome studies and likely reflect the intricate interplay between malignant cells and the tumor microenvironment (TME) [59–61].”
From PPP1R18-mediated activation of Wnt/β-catenin and EMT is dependent on ERK signaling in clear cell renal cell carcinoma (2026) · cites this paper as [59]
In the citing paper
“In fact, an epigenetic reprogramming, including abnormal DNA methylation patterns, is a common alteration in the tumorigenic process, independently of the cell of origin [17].”
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Self-citationHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Self-citationAccessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 2×
“In general, the accessory cells in the tumor microenvironment that functionally contribute to the acquisition of hallmark capabilities are not thought to suffer genetic instability and mutational reprogramming to enhance their tumor-promoting activities; rather it is inferred that these cells—cancer-associated fibrobl…”
BackgroundSelf-citationCellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 1×
“Senescence can be induced in cells by a variety of conditions, including microenvironmental stresses such as nutrient deprivation and DNA damage, as well as damage to organelles and cellular infrastructure, and imbalances in cellular signaling networks (115, 117), all of which have been associated with the observed in…”
BackgroundNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876 · cited 1×
“In one illuminating case study, senescent cells were pharmacologically ablated in aging mice, in particular depleting senescent cells characteristically expressing the cell-cycle inhibitor p16−INK4a: in addition to delaying multiple age-related symptoms, the depletion of senescent cells in aging mice resulted in reduc…”
BackgroundPuram, S. V., Tirosh, I., Parikh, A. S., Patel, A. P., Yizhak, K., Gillespie, S., Rodman, C., Luo, C. L., Mroz, E. A., Emerick, K. S., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.044 · Cited by 2,557 · cited 1×
“Another example of epigenetically regulated plasticity has been described in human oral squamous cell carcinomas (SCC), wherein cancer cells at the invasive margins adopt a partial EMT (p-EMT) state lacking the aforementioned mesenchymal TFs but expressing other EMT-defining genes that are not expressed in the central…”
BackgroundEpigenetics: A landscape takes shape
Goldberg, A. D., Allis, C. D., & Bernstein, E. (2007) · Cell · doi:10.1016/j.cell.2007.02.006 · Cited by 2,466
The human tumor microbiome is composed of tumor type–specific intracellular bacteria
Nejman, D., Livyatan, I., Fuks, G., Gavert, N., Zwang, Y., Geller, L. T., Rotter-Maskowitz, A., Weiser, R., Mallel, G., Gigi, E., et al. (2020) · Science · doi:10.1126/science.aay9189 · Cited by 2,464 · cited 1×
“For example, in a survey of 1,526 tumors encompassing seven human cancer types (bone, brain, breast, lung, melanoma, ovary, and pancreas), each type was characterized by a distinctive microbiome that was largely localized inside cancer cells and immune cells, and within each tumor type, variations in the tumor microbi…”
BackgroundMachine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Malta, T. M., Sokolov, A., Gentles, A. J., Burzykowski, T., Poisson, L., Weinstein, J. N., Kamińska, B., Huelsken, J., Omberg, L., Gevaert, O., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.034 · Cited by 2,180
Crypt stem cells as the cells-of-origin of intestinal cancer
Barker, N., Ridgway, R. A., van Es, J. H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Clarke, A. R., Sansom, O. J., & Clevers, H. (2009) · Nature · doi:10.1038/nature07602 · Cited by 2,166
Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients
Davar, D., Dzutsev, A. K., McCulloch, J. A., Rodrigues, R. R., Chauvin, J.-M., Morrison, R. M., Deblasio, R. N., Menna, C., Ding, Q., Pagliano, O., et al. (2021) · Science · doi:10.1126/science.abf3363 · Cited by 1,781 · cited 1×
“Provisional proof-of-concept has come from recent studies demonstrating restored efficacy to immunotherapy following transplants of fecal microbiota from therapyresponsive patients into patients with melanoma who had progressed during prior treatment with immune checkpoint blockade (97, 98).”
BackgroundSenescence in Health and Disease
He, S., & Sharpless, N. E. (2017) · Cell · doi:10.1016/j.cell.2017.05.015 · Cited by 1,766 · cited 3×
“Indeed, there are well-established examples of the protective benefits of senescence in limiting malignant progression (118, 119).”
BackgroundFecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Baruch, E. N., Youngster, I., Ben-Betzalel, G., Ortenberg, R., Lahat, A., Katz, L., Adler, K., Dick-Necula, D., Raskin, S., Bloch, N., et al. (2021) · Science · doi:10.1126/science.abb5920 · Cited by 1,757 · cited 1×
“Provisional proof-of-concept has come from recent studies demonstrating restored efficacy to immunotherapy following transplants of fecal microbiota from therapyresponsive patients into patients with melanoma who had progressed during prior treatment with immune checkpoint blockade (97, 98).”
BackgroundMicrobiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
Mager, L. F., Burkhard, R., Pett, N., Cooke, N. C. A., Brown, K., Ramay, H., Paik, S., Stagg, J., Groves, R. A., Gallo, M., et al. (2020) · Science · doi:10.1126/science.abc3421 · Cited by 1,407 · cited 1×
“Other immunoregulatory molecules produced by specific bacterial subspecies are being identified and functionally evaluated, including bacteria-produced inosine, a rate-limiting metabolite for T-cell activity (100).”
BackgroundPushalkar, S., Hundeyin, M., Daley, D., Zambirinis, C. P., Kurz, E., Mishra, A., Mohan, N., Aykut, B., Usyk, M., Torres, L. E., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1134 · Cited by 1,400 · cited 1×
“Microbiota have been similarly detected in genetically engineered de novo mouse models of lung and pancreas cancer, and their absence in germ-free mice and/or their abrogation with antibiotics can demonstrably impair tumorigenesis, functionally implicating the tumor microbiome as an enabler of tumor-promoting inflamma…”
BackgroundThe Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
Gopalakrishnan, V., Helmink, B. A., Spencer, C. N., Reuben, A., & Wargo, J. A. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.015 · Cited by 1,392 · cited 1×
“Beyond the causal links to colon cancer and melanoma, the gut microbiome’s demonstrable ability to elicit the expression of immunomodulatory chemokines and cytokines that enter the systemic circulation is evidently also capable of affecting cancer pathogenesis and response to therapy in other organs of the body (94, 9…”
BackgroundEpigenetic plasticity and the hallmarks of cancer
Flavahan, W. A., Gaskell, E., & Bernstein, B. E. (2017) · Science · doi:10.1126/science.aal2380 · Cited by 1,340
The chromatin accessibility landscape of primary human cancers
Corces, M. R., Granja, J. M., Shams, S., Louie, B. H., Seoane, J. A., Zhou, W., Silva, T. C., Groeneveld, C., Wong, C. K., Cho, S. W., et al. (2018) · Science · doi:10.1126/science.aav1898 · Cited by 1,230 · cited 1×
“Epigenomic heterogeneity is being revealed by increasingly powerful technologies for profiling genomewide DNA methylation (79, 80), histone modification (81), chromatin accessibility (82), and posttranscriptional modification and translation of RNA (83, 84).”
BackgroundEpigenetic Determinants of Cancer
Baylin, S. B., & Jones, P. A. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019505 · Cited by 1,226
Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli
Pleguezuelos-Manzano, C., Puschhof, J., Rosendahl Huber, A., van Hoeck, A., Wood, H. M., Nomburg, J., Gurjao, C., Manders, F., Dalmasso, G., Stege, P. B., et al. (2020) · Nature · doi:10.1038/s41586-020-2080-8 · Cited by 1,208
The microbiome, cancer, and cancer therapy
Helmink, B. A., Khan, M. A. W., Hermann, A., Gopalakrishnan, V., & Wargo, J. A. (2019) · Nature Medicine · doi:10.1038/s41591-019-0377-7 · Cited by 1,200 · cited 1×
“For cancer, the evidence is increasingly compelling that polymorphic variability in the microbiomes between individuals in a population can have a profound impact on cancer phenotypes (88, 89).”
BackgroundSenescence and the SASP: many therapeutic avenues
Birch, J., & Gil, J. (2020) · Genes & Development · doi:10.1101/gad.343129.120 · Cited by 1,177 · cited 7×
“Senescence can be induced in cells by a variety of conditions, including microenvironmental stresses such as nutrient deprivation and DNA damage, as well as damage to organelles and cellular infrastructure, and imbalances in cellular signaling networks (115, 117), all of which have been associated with the observed in…”
BackgroundInfluentialTargeting the cancer epigenome for therapy
Jones, P. A., Issa, J.-P. J., & Baylin, S. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.93 · Cited by 1,128
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
Von Hoff, D. D., LoRusso, P. M., Rudin, C. M., Reddy, J. C., Yauch, R. L., Tibes, R., Weiss, G. J., Borad, M. J., Hann, C. L., Brahmer, J. R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905360 · Cited by 1,109 · cited 1×
“A third example also reveals transdifferentiation as a strategy employed by carcinoma cells to avoid elimination by a lineage-specific therapy, in this case involving basal cell carcinomas (BCC) of the skin treated with a pharmacologic inhibitor of the Hedgehog-Smoothened (HH/SMO) oncogenic signaling pathway known to…”
BackgroundSenolytic CAR T cells reverse senescence-associated pathologies
Amor, C., Feucht, J., Leibold, J., Ho, Y.-J., Zhu, C., Alonso-Curbelo, D., Mansilla-Soto, J., Boyer, J. A., Li, X., Giavridis, T., et al. (2020) · Nature · doi:10.1038/s41586-020-2403-9 · Cited by 1,098
Mu, P., Zhang, Z., Benelli, M., Karthaus, W. R., Hoover, E., Chen, C.-C., Wongvipat, J., Ku, S.-Y., Gao, D., Cao, Z., et al. (2017) · Science · doi:10.1126/science.aah4307 · Cited by 1,050 · cited 1×
“In addition to loss of RB and p53, the acquired resistance to antiandrogen therapy requires upregulated expression of the SOX2 developmental regulatory gene, which is demonstrably instrumental in inducing transdifferentiation of the therapy-responsive adenocarcinoma cells into derivatives that reside in a neuroendocri…”
BackgroundHistone Modifications and Cancer
Audia, J. E., & Campbell, R. M. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019521 · Cited by 1,024 · cited 1×
“Epigenomic heterogeneity is being revealed by increasingly powerful technologies for profiling genomewide DNA methylation (79, 80), histone modification (81), chromatin accessibility (82), and posttranscriptional modification and translation of RNA (83, 84).”
BackgroundEMT, MET, Plasticity, and Tumor Metastasis
Bakir, B., Chiarella, A. M., Pitarresi, J. R., & Rustgi, A. K. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.07.003 · Cited by 1,010
Commensal Microbiota Promote Lung Cancer Development via γδ T Cells
Jin, C., Lagoudas, G. K., Zhao, C., Bullman, S., Bhutkar, A., Hu, B., Ameh, S., Sandel, D., Liang, X. S., Mazzilli, S., et al. (2019) · Cell · doi:10.1016/j.cell.2018.12.040 · Cited by 964 · cited 1×
“Microbiota have been similarly detected in genetically engineered de novo mouse models of lung and pancreas cancer, and their absence in germ-free mice and/or their abrogation with antibiotics can demonstrably impair tumorigenesis, functionally implicating the tumor microbiome as an enabler of tumor-promoting inflamma…”
BackgroundDynamics and associations of microbial community types across the human body
Ding, T., & Schloss, P. D. (2014) · Nature · doi:10.1038/nature13178 · Cited by 885 · cited 2×
“Virtually all tissues and organs exposed, directly or indirectly, to the outside environment are also repositories for commensal microorganisms (104).”
BackgroundUnmasking senescence: context-dependent effects of SASP in cancer
Faget, D. V., Ren, Q., & Stewart, S. A. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0156-2 · Cited by 863 · cited 8×
“Thus, in different experimental systems, senescent cancer cells have been shown to variously contribute to proliferative signaling, avoiding apoptosis, inducing angiogenesis, stimulating invasion and metastasis, and suppressing tumor immunity (116, 118, 120, 121).”
BackgroundInfluentialMicrobes, Microbiota, and Colon Cancer
Sears, C. L., & Garrett, W. S. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.007 · Cited by 818 · cited 1×
“In recent years, persuasive functional studies, involving fecal transplants from colon tumor–bearing patients and mice into recipient mice predisposed to develop colon cancer has established a principle: there are both cancer-protective and tumor-promoting microbiomes, involving particular bacterial species, which can…”
BackgroundSerrano-Gomez, S. J., Maziveyi, M., & Alahari, S. K. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0502-x · Cited by 814
The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
Zitvogel, L., Ma, Y., Raoult, D., Kroemer, G., & Gajewski, T. F. (2018) · Science · doi:10.1126/science.aar6918 · Cited by 777
Warrell, R. P., de The, H., Wang, Z.-Y., & Degos, L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307153290307 · Cited by 776
The great escape: tumour cell plasticity in resistance to targeted therapy
Boumahdi, S., & de Sauvage, F. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0044-1 · Cited by 761 · cited 1×
“Such transdifferentiation to enable drug resistance is being increasingly documented in different forms of cancer (35).”
BackgroundThe Varied Roles of Notch in Cancer
Aster, J. C., Pear, W. S., & Blacklow, S. C. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100127 · Cited by 710
Kopp, J. L., von Figura, G., Mayes, E., Liu, F.-F., Dubois, C. L., Morris, J. P., Pan, F. C., Akiyama, H., Wright, C. V. E., Jensen, K., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.025 · Cited by 697 · cited 1×
“Forced upregulation of SOX9, obviating the need to downregulate PTF1a and MIST1, has also been shown to stimulate transdifferentiation of acinar cells into a ductal cell phenotype that is sensitive to KRAS-induced neoplasia (29), implicating SOX9 as a key functional effector of their downregulation in the genesis of h…”
Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
Gupta, P. B., Pastushenko, I., Skibinski, A., Blanpain, C., & Kuperwasser, C. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.11.011 · Cited by 598
The dynamic nature of senescence in cancer
Lee, S., & Schmitt, C. A. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0249-2 · Cited by 588 · cited 2×
“Thus, in different experimental systems, senescent cancer cells have been shown to variously contribute to proliferative signaling, avoiding apoptosis, inducing angiogenesis, stimulating invasion and metastasis, and suppressing tumor immunity (116, 118, 120, 121).”
BackgroundThe dormant cancer cell life cycle
Phan, T. G., & Croucher, P. I. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0263-0 · Cited by 576 · cited 1×
“An additional, related concept is “circumvented differentiation,” wherein partially or undifferentiated progenitor/ stem cells exit the cell cycle and become dormant, residing in protective niches, with the potential to reinitiate proliferative expansion (24), albeit still with the selective pressure to disrupt their…”
BackgroundLinking EMT programmes to normal and neoplastic epithelial stem cells
Lambert, A. W., & Weinberg, R. A. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00332-6 · Cited by 534
Salvi, P. S., & Cowles, R. A. (2021) · Cells · doi:10.3390/cells10071775 · Cited by 526 · cited 1×
“In addition, bacterialproduced butyrate has pleiotropic and paradoxical effects on differentiated cells versus undifferentiated (stem) cells in the colonic epithelium in conditions where the intestinal barrier is disrupted (dysbiosis) and the bacteria are invasive, affecting, for example, cellular energetics and metab…”
BackgroundSenescent Cells in Cancer Therapy: Friends or Foes?
Wang, B., Kohli, J., & Demaria, M. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.05.004 · Cited by 508
Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis
Ruhland, M. K., Loza, A. J., Capietto, A.-H., Luo, X., Knolhoff, B. L., Flanagan, K. C., Belt, B. A., Alspach, E., Leahy, K., Luo, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms11762 · Cited by 496 · cited 1×
“Additionally, senescent fibroblasts in aging skin have been shown to recruit—via their SASP—innate immune cells that are both immunosuppressive of adaptive antitumoral immune responses anchored by CD8 T cells, and stimulatory of skin tumor growth (123), with the latter effect potentially reflecting paracrine contribut…”
BackgroundThe role of SOX family members in solid tumours and metastasis
Grimm, D., Bauer, J., Wise, P., Krüger, M., Simonsen, U., Wehland, M., Infanger, M., & Corydon, T. J. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.03.004 · Cited by 487 · cited 1×
“Additional members of the SOX family of chromatinassociated regulatory factors are on the one hand broadly associated both with cell fate specification and lineage switching in development (30), and on the other with multiple tumor-associated phenotypes (31).”
BackgroundCancer epigenetics: Moving forward
Nebbioso, A., Tambaro, F. P., Dell’Aversana, C., & Altucci, L. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007362 · Cited by 480
The Human Oral Microbiome in Health and Disease: From Sequences to Ecosystems
Willis, J. R., & Gabaldón, T. (2020) · Microorganisms · doi:10.3390/microorganisms8020308 · Cited by 468
Differentiation therapy revisited
de Thé, H. (2018) · Nature reviews. Cancer · doi:10.1038/nrc.2017.103 · Cited by 462 · cited 1×
“Myeloid progenitor cells bearing such translocations are evidently unable to continue their usual terminal differentiation into granulocytes, resulting in cells trapped in a proliferative, promyelocytic progenitor stage (14).”
BackgroundMutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer
Saha, S. K., Parachoniak, C. A., Ghanta, K. S., Fitamant, J., Ross, K. N., Najem, M. S., Gurumurthy, S., Akbay, E. A., Sia, D., Cornella, H., et al. (2014) · Nature · doi:10.1038/nature13441 · Cited by 460 · cited 2×
“A variation on this theme involves another form of acute myeloid leukemia, this one carrying the t(8;21) translocation, which produces the AML1–ETO fusion protein.”
BackgroundYuan, S., Norgard, R. J., & Stanger, B. Z. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0015 · Cited by 455 · cited 2×
“The concept of transdifferentiation has long been recognized by pathologists in the form of tissue metaplasia, wherein cells of a particular differentiated phenotype markedly change their morphology to become clearly recognizable as elements of another tissue, of which one prominent example is Barrett’s esophagus, whe…”
BackgroundKuczynski, E. A., Vermeulen, P. B., Pezzella, F., Kerbel, R. S., & Reynolds, A. R. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0181-9 · Cited by 446 · cited 1×
“Given the growing appreciation that tumors can become sufficiently vascularized either by switching on angiogenesis or by co-opting normal tissue vessels (128), this hallmark is also more broadly defined as the capability to induce or otherwise access, principally by invasion and metastasis, vasculature that supports…”
BackgroundPan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity
Kinker, G. S., Greenwald, A. C., Tal, R., Orlova, Z., Cuoco, M. S., McFarland, J. M., Warren, A., Rodman, C., Roth, J. A., Bender, S. A., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-00726-6 · Cited by 445 · cited 1×
“Notably, this conclusion is supported by analysis of 198 cell lines representing 22 cancer types, including SCC, wherein 12 stably heterogeneous epigenetic states (including the p-EMT in SCC) were variously detected in the cell line models as well as their cognate primary tumors (75).”
ResultEmergence of a High-Plasticity Cell State during Lung Cancer Evolution
Marjanovic, N. D., Hofree, M., Chan, J. E., Canner, D., Wu, K., Trakala, M., Hartmann, G. G., Smith, O. C., Kim, J. Y., Evans, K. V., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.012 · Cited by 405
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation
Kaufman, C. K., Mosimann, C., Fan, Z. P., Yang, S., Thomas, A. J., Ablain, J., Tan, J. L., Fogley, R. D., van Rooijen, E., Hagedorn, E. J., et al. (2016) · Science · doi:10.1126/science.aad2197 · Cited by 398 · cited 1×
“Gain- and loss-of-function studies in a zebrafish model of BRAF-induced melanoma have demonstrated that aberrantly maintained expression of SOX10 blocks differentiation of neural progenitor cells into melanocytes, enabling BRAF-driven melanomas to form (19).”
BackgroundIntegrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics
Nam, A. S., Chaligne, R., & Landau, D. A. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-020-0265-5 · Cited by 378
The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic
Kadosh, E., Snir-Alkalay, I., Venkatachalam, A., May, S., Lasry, A., Elyada, E., Zinger, A., Shaham, M., Vaalani, G., Mernberger, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2541-0 · Cited by 378 · cited 1×
“There are clues that particular bacterial species can directly stimulate the hallmark of proliferative signaling, for example, in colonic epithelium (88), and modulate growth suppression by altering tumor suppressor activity in different compartments of the intestine (114), whereas direct effects on other hallmark cap…”
BackgroundTop-down morphogenesis of colorectal tumors
Shih, I.-M., Wang, T.-L., Traverso, G., Romans, K., Hamilton, S. R., Ben-Sasson, S., Kinzler, K. W., & Vogelstein, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051629398 · Cited by 377
Adult cell plasticity in vivo: de-differentiation and transdifferentiation are back in style
Merrell, A. J., & Stanger, B. Z. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.24 · Cited by 369 · cited 1×
“Finally, as with other hallmark capabilities, cellular plasticity is not a novel invention or aberration of cancer cells, but rather the corruption of latent but activatable capabilities that various normal cells use to support homeostasis, repair, and regeneration (45).”
BackgroundThomas, S., Izard, J., Walsh, E., Batich, K., Chongsathidkiet, P., Clarke, G., Sela, D. A., Muller, A. J., Mullin, J. M., Albert, K., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2929 · Cited by 367 · cited 2×
“There is growing appreciation that the ecosystems created by resident bacteria and fungi—the microbiomes—have profound impact on health and disease (87), a realization fueled by the capability to audit the populations of microbial species using next-generation sequencing and bioinformatic technologies.”
BackgroundEnterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy
Griffin, M. E., Espinosa, J., Becker, J. L., Luo, J.-D., Carroll, T. S., Jha, J. K., Fanger, G. R., & Hang, H. C. (2021) · Science · doi:10.1126/science.abc9113 · Cited by 366 · cited 1×
“A recent study has shed some light: certain strains of Enterococcus (and other bacteria) express a peptidoglycan hydrolyase called SagA that releases mucopeptides from the bacterial wall, which can then circulate systemically and activate the NOD2 pattern receptor, which in turn can enhance T-cell responses and the ef…”
BackgroundPan-Cancer Landscape of Aberrant DNA Methylation across Human Tumors
Saghafinia, S., Mina, M., Riggi, N., Hanahan, D., & Ciriello, G. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.082 · Cited by 357 · cited 1×
“Epigenomic heterogeneity is being revealed by increasingly powerful technologies for profiling genomewide DNA methylation (79, 80), histone modification (81), chromatin accessibility (82), and posttranscriptional modification and translation of RNA (83, 84).”
BackgroundSelf-citationMechanisms and impact of altered tumour mechanics
Mohammadi, H., & Sahai, E. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0131-2 · Cited by 336 · cited 1×
“Compared with the normal tissue ECM from which tumors originate, the tumor ECM is typically characterized by increased cross-linking and density, enzymatic modifications, and altered molecular composition, which collectively orchestrate—in part via integrin receptors for ECM motifs—stiffness-induced signaling and gene…”
BackgroundBiological Role and Therapeutic Potential of IDH Mutations in Cancer
Waitkus, M. S., Diplas, B. H., & Yan, H. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.04.011 · Cited by 335 · cited 1×
“Mutant IDH1/2 and their oncometabolite D2HG are also operative in a variety of myeloid and other solid tumor types, where D2HG inhibits αKG-dependent dioxygenases necessary for histone and DNA methylation events that mediate alterations in chromatin structure during developmental lineage differentiation, thereby freez…”
BackgroundEpigenetic therapy inhibits metastases by disrupting premetastatic niches
Lu, Z., Zou, J., Li, S., Topper, M. J., Tao, Y., Zhang, H., Jiao, X., Xie, W., Kong, X., Vaz, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2054-x · Cited by 330 · cited 1×
“For example, a recent study (86) suggests that such reprogramming can involve modifications of the epigenome in addition to the inductive interchange of cytokines, chemokines, and growth factors that alter intracellular signaling networks in all of these cell types: when mouse models of metastasis to lung were treated…”
BackgroundDNA Methylation Reprogramming during Mammalian Development
Zeng, Y., & Chen, T. (2019) · Genes · doi:10.3390/genes10040257 · Cited by 321
Exploring the emerging role of the microbiome in cancer immunotherapy
Fessler, J., Matson, V., & Gajewski, T. F. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0574-4 · Cited by 319 · cited 1×
“Beyond the causal links to colon cancer and melanoma, the gut microbiome’s demonstrable ability to elicit the expression of immunomodulatory chemokines and cytokines that enter the systemic circulation is evidently also capable of affecting cancer pathogenesis and response to therapy in other organs of the body (94, 9…”
BackgroundDzutsev, A., Badger, J. H., Perez-Chanona, E., Roy, S., Salcedo, R., Smith, C. K., & Trinchieri, G. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052133 · Cited by 302 · cited 3×
“For cancer, the evidence is increasingly compelling that polymorphic variability in the microbiomes between individuals in a population can have a profound impact on cancer phenotypes (88, 89).”
BackgroundControl of Immunity by the Microbiota
Ansaldo, E., Farley, T. K., & Belkaid, Y. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-093019-112348 · Cited by 298 · cited 1×
“These examples and others are beginning to chart the molecular mechanisms by which polymorphic microbiomes are indirectly and systemically modulating tumor immunobiology, above and beyond immune responses consequent to direct physical interactions of bacteria with the immune system (101, 102).”
Backgroundα-Ketoglutarate links p53 to cell fate during tumour suppression
Morris, J. P., Yashinskie, J. J., Koche, R., Chandwani, R., Tian, S., Chen, C.-C., Baslan, T., Marinkovic, Z. S., Sánchez-Rivera, F. J., Leach, S. D., et al. (2019) · Nature · doi:10.1038/s41586-019-1577-5 · Cited by 296 · cited 1×
“In pancreas cancer, the tumor suppressor p53 stimulates the production of αKG and maintenance of a more well-differentiated cell state, whereas prototypical loss of p53 function results in reductions in αKG levels and consequent dedifferentiation associated with malignant progression (20).”
BackgroundEpithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity
Skrypek, N., Goossens, S., De Smedt, E., Vandamme, N., & Berx, G. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.08.004 · Cited by 271 · cited 1×
“Furthermore, a roster of conditions and factors to which cancer cells at the margins of tumors are exposed, including hypoxia and cytokines secreted by stromal cells, can evidently induce the EMT and in turn invasiveness (67, 68).”
BackgroundGut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion
Okumura, S., Konishi, Y., Narukawa, M., Sugiura, Y., Yoshimoto, S., Arai, Y., Sato, S., Yoshida, Y., Tsuji, S., Uemura, K., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25965-x · Cited by 259 · cited 2×
“A mouse model of colon carcinogenesis populated with butyrate-producing bacteria developed more tumors than mice lacking such bacteria; the connection between butyrate-induced senescence and enhanced colon tumorigenesis was demonstrated by the use of a senolytic drug that kills senescent cells, which impaired tumor gr…”
BackgroundGut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma
Zhang, Q., Ma, C., Duan, Y., Heinrich, B., Rosato, U., Diggs, L. P., Ma, L., Roy, S., Fu, Q., Brown, Z. J., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0304 · Cited by 257 · cited 1×
“An illuminating example involves the development of cholangiocarcinomas in the liver: gut dysbiosis allows the entry and transport of bacteria and bacterial products through the portal vein to the liver, where TLR4 expressed on hepatocytes is triggered to induce expression of the chemokine CXCL1, which recruits CXCR2e…”
BackgroundEpigenomic State Transitions Characterize Tumor Progression in Mouse Lung Adenocarcinoma
LaFave, L. M., Kartha, V. K., Ma, S., Meli, K., Del Priore, I., Lareau, C., Naranjo, S., Westcott, P. M. K., Duarte, F. M., Sankar, V., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.006 · Cited by 220 · cited 1×
“Regulatory determinants of this dynamic phenotypic plasticity are beginning to be identified (37, 39, 40).”
BackgroundEpigenetic regulation and chromatin remodeling in learning and memory
Kim, S., & Kaang, B.-K. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.140 · Cited by 213 · cited 1×
“In the adult, for example, long-term memory involves changes in gene and histone modification, in chromatin structure, and in the triggering of gene expression switches that are stably maintained over time by positive and negative feedback loops (56, 57).”
BackgroundHOXA5 Counteracts Stem Cell Traits by Inhibiting Wnt Signaling in Colorectal Cancer
Ordóñez-Morán, P., Dafflon, C., Imajo, M., Nishida, E., & Huelsken, J. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.11.001 · Cited by 209 · cited 1×
“Functional perturbations in mouse models have shown that forced expression of HOXA5 in colon cancer cells restores differentiation markers, suppresses stem cell phenotypes, and impairs invasion and metastasis, providing a rationale for its characteristic downregulation (7, 8).”
BackgroundEpigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer
Heyn, H., Vidal, E., Ferreira, H. J., Vizoso, M., Sayols, S., Gomez, A., Moran, S., Boque-Sastre, R., Guil, S., Martinez-Cardus, A., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-0879-2 · Cited by 208 · cited 1×
“Epigenomic heterogeneity is being revealed by increasingly powerful technologies for profiling genomewide DNA methylation (79, 80), histone modification (81), chromatin accessibility (82), and posttranscriptional modification and translation of RNA (83, 84).”
BackgroundDang, L., & Su, S.-S. M. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-044732 · Cited by 204 · cited 1×
“Mutant IDH1/2 and their oncometabolite D2HG are also operative in a variety of myeloid and other solid tumor types, where D2HG inhibits αKG-dependent dioxygenases necessary for histone and DNA methylation events that mediate alterations in chromatin structure during developmental lineage differentiation, thereby freez…”
BackgroundWriters, readers and erasers of RNA modifications in cancer
Esteve-Puig, R., Bueno-Costa, A., & Esteller, M. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.021 · Cited by 203 · cited 3×
“Rather, upregulation of a miRNA previously implicated in specifying the islet progenitor state, one that is downregulated during terminal differentiation of β cells, has been shown to orchestrate the observed dedifferentiation occurring during malignant progression (12).”
BackgroundThe linker histone H1.0 generates epigenetic and functional intratumor heterogeneity
Torres, C. M., Biran, A., Burney, M. J., Patel, H., Henser-Brownhill, T., Cohen, A.-H. S., Li, Y., Ben-Hamo, R., Nye, E., Spencer-Dene, B., et al. (2016) · Science · doi:10.1126/science.aaf1644 · Cited by 193 · cited 1×
“0, which is dynamically expressed and repressed in subpopulations of cancer cells within a number of tumor types, with consequent sequestration or accessibility, respectively, of megabase-sized domains, including ones conveying hallmark capabilities (73).”
BackgroundHijacking the Neuronal NMDAR Signaling Circuit to Promote Tumor Growth and Invasion
Li, L., & Hanahan, D. (2013) · Cell · doi:10.1016/j.cell.2013.02.051 · Cited by 192 · cited 1×
“A distinctive example of microenvironmental programming of invasiveness, ostensibly unrelated to the EMT program, involves autocrine activation, in pancreas cancer cells and others, via interstitial pressure–driven fluid flow, of a neuronal signaling circuit involving secreted glutamate and its receptor NMDAR (69, 70).”
BackgroundSelf-citationOn the evolution of cellular senescence
Kowald, A., Passos, J. F., & Kirkwood, T. B. L. (2020) · Aging Cell · doi:10.1111/acel.13270 · Cited by 179 · cited 3×
“Indeed, there are well-established examples of the protective benefits of senescence in limiting malignant progression (118, 119).”
BackgroundLiving in Your Skin: Microbes, Molecules, and Mechanisms
Swaney, M. H., & Kalan, L. R. (2021) · Infection and Immunity · doi:10.1128/iai.00695-20 · Cited by 178
The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma
Krah, N. M., De La O, J.-P., Swift, G. H., Hoang, C. Q., Willet, S. G., Chen Pan, F., Cash, G. M., Bronner, M. P., Wright, C. V., MacDonald, R. J., et al. (2015) · eLife · doi:10.7554/elife.07125 · Cited by 166 · cited 6×
“One illuminating case for transdifferentiation as a discrete event in tumorigenesis involves pancreatic ductal adenocarcinoma (PDAC), wherein one of the implicated cells of origin, the pancreatic acinar cell, can become transdifferentiated into a ductal cell phenotype during the initiation of neoplastic development.”
BackgroundInfluentialEpigenetic mechanisms and the hallmarks of cancer: an intimate affair.
Darwiche, N. (2020) · PubMed · Cited by 163
Shi, G., DiRenzo, D., Qu, C., Barney, D., Miley, D., & Konieczny, S. F. (2013) · Oncogene · doi:10.1038/onc.2012.210 · Cited by 162 · cited 2×
“Loss of either PTF1 or MIST1 expression during tumorigenesis is associated with elevated expression of another developmental regulatory TF, SOX9, which is normally operative in the specification of ductal cells (27, 28).”
BackgroundHwang, H. J., Lee, Y.-R., Kang, D., Lee, H. C., Seo, H. R., Ryu, J.-K., Kim, Y.-N., Ko, Y.-G., Park, H. J., & Lee, J.-S. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.06.019 · Cited by 157 · cited 1×
“For example, therapy-induced senescent tumor endothelial cells can enhance proliferation, invasion, and metastasis in breast cancer models (124, 125).”
BackgroundNongenetic Evolution Drives Lung Adenocarcinoma Spatial Heterogeneity and Progression
Tavernari, D., Battistello, E., Dheilly, E., Petruzzella, A. S., Mina, M., Sordet‐Dessimoz, J., Peters, S., Krueger, T., Gfeller, D., Riggi, N., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1274 · Cited by 153
Dravis, C., Chung, C.-Y., Lytle, N. K., Herrera-Valdez, J., Luna, G., Trejo, C. L., Reya, T., & Wahl, G. M. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.08.001 · Cited by 141
The Tumor Microbiome in Pancreatic Cancer: Bacteria and Beyond
McAllister, F., Khan, M. A. W., Helmink, B., & Wargo, J. A. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.11.004 · Cited by 138 · cited 1×
“Association studies in human pancreatic ductal adenocarcinoma and functional tests via fecal transplants into tumor-bearing mice have established that variations in the tumor microbiome— and the associated gut microbiome—modulate immune phenotypes and survival (113).”
BackgroundA cell identity switch allows residual BCC to survive Hedgehog pathway inhibition
Biehs, B., Dijkgraaf, G. J. P., Piskol, R., Alicke, B., Boumahdi, S., Peale, F., Gould, S. E., & de Sauvage, F. J. (2018) · Nature · doi:10.1038/s41586-018-0596-y · Cited by 137 · cited 1×
“The newly gained phenotypic state of the BCC cells enables them to sustain expression of the WNT oncogenic signaling pathway, which in turn imparts independence from the drug-suppressed HH/ SMO signaling pathway (34).”
BackgroundMetabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma
Michealraj, K. A., Kumar, S. A., Kim, L. J. Y., Cavalli, F. M. G., Przelicki, D., Wojcik, J. B., Delaidelli, A., Bajic, A., Saulnier, O., MacLeod, G., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.047 · Cited by 134 · cited 1×
“Rather, the aberrant growth of these cancer cells is demonstrably governed by a gene regulatory program induced by hypoxia (60, 61).”
BackgroundBots, M., Verbrugge, I., Martin, B. P., Salmon, J. M., Ghisi, M., Baker, A., Stanley, K., Shortt, J., Ossenkoppele, G. J., Zuber, J., et al. (2014) · Blood · doi:10.1182/blood-2013-03-488114 · Cited by 133 · cited 1×
“Concomitant with this response is a reduction in proliferative capacity, thereby impairing the progression of this leukemia (17, 18).”
BackgroundKöhler, C., Nittner, D., Rambow, F., Radaelli, E., Stanchi, F., Vandamme, N., Baggiolini, A., Sommer, L., Berx, G., van den Oord, J. J., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.08.003 · Cited by 126 · cited 1×
“Moreover, a lineage tracing study of BRAF-induced melanomas established mature pigmented melanocytes as the cells of origin, which undergo dedifferentiation during the course of tumorigenesis (9).”
BackgroundJavaid, S., Zhang, J., Anderssen, E., Black, J. C., Wittner, B. S., Tajima, K., Ting, D. T., Smolen, G. A., Zubrowski, M., Desai, R., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.11.034 · Cited by 118 · cited 1×
“A previous study similarly documented that induction of EMT by upregulated expression of a related TF, SNAIL1, caused marked alterations in the chromatin landscape consequent to induction of a number of chromatin modifiers, whose activity was demonstrably necessary for the maintenance of the phenotypic state (66).”
BackgroundHe, L.-Z., Merghoub, T., & Pandolfi, P. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203088 · Cited by 116
The microbiome and oral cancer: More questions than answers
Healy, C. M., & Moran, G. P. (2019) · Oral Oncology · doi:10.1016/j.oraloncology.2018.12.003 · Cited by 108
EMT transcription factor ZEB1 alters the epigenetic landscape of colorectal cancer cells
Lindner, P., Paul, S., Eckstein, M., Hampel, C., Muenzner, J. K., Erlenbach‐Wuensch, K., Pallikonda, H. A., Mahadevan, V., Brabletz, T., Hartmann, A., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2340-4 · Cited by 106 · cited 1×
“Notably, a master regulator of the EMT, ZEB1, has been recently shown to induce expression of a histone methyltransferase, SETD1B, that in turn sustains ZEB1 expression in a positive feedback loop that maintains the (invasive) EMT regulatory state (65).”
BackgroundMu, P., Zhang, Z., Benelli, M., Karthaus, W. R., Hoover, E., Chen, C.-C., Wongvipat, J., Ku, S.-Y., Gao, D., Cao, Z., et al. (n.d.) · doi:10.7892/boris.110876 · Cited by 105
Gameiro, P. A., & Struhl, K. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.021 · Cited by 99 · cited 1×
“Insufficient vascularization likely also limits the bioavailability of critical blood-borne nutrients, and nutrient deprivation has been shown for example to alter translational control and consequently enhance the malignant phenotype of breast cancer cells (59).”
BackgroundTumor progression: Chance and necessity in Darwinian and Lamarckian somatic (mutationless) evolution
Huang, S. (2012) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2012.05.001 · Cited by 90 · cited 1×
“Indeed, the proposition of mutation-less cancer evolution and purely epigenetic programming of hallmark cancer phenotypes was raised almost a decade ago (49) and is increasingly discussed (46, 50–52).”
BackgroundDirect reprogramming with SOX factors: masters of cell fate
Julian, L. M., McDonald, A. C., & Stanford, W. L. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.06.005 · Cited by 90 · cited 1×
“Additional members of the SOX family of chromatinassociated regulatory factors are on the one hand broadly associated both with cell fate specification and lineage switching in development (30), and on the other with multiple tumor-associated phenotypes (31).”
BackgroundMiao, Z., Lewis, M. A., Cho, C. J., Adkins-Threats, M., Park, D., Brown, J. W., Sun, J.-X., Burclaff, J., Kennedy, S., Lu, J., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.07.005 · Cited by 89
Plasticity of tumor cell invasion: governance by growth factors and cytokines
Odenthal, J., Takes, R. P., & Friedl, P. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw098 · Cited by 86 · cited 1×
“In addition to such regulatory mechanisms endowed by the physical tumor microenvironment, paracrine signaling involving soluble factors released into the extracellular milieu by the various cell types populating solid tumors can also contribute to the induction of several morphologically distinct invasive growth progr…”
BackgroundGKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor Growth
Li, L., Zeng, Q., Bhutkar, A., Galván, J. A., Karamitopoulou, E., Noordermeer, D., Peng, M.-W., Piersigilli, A., Perren, A., Zlobec, I., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.02.011 · Cited by 85 · cited 1×
“A distinctive example of microenvironmental programming of invasiveness, ostensibly unrelated to the EMT program, involves autocrine activation, in pancreas cancer cells and others, via interstitial pressure–driven fluid flow, of a neuronal signaling circuit involving secreted glutamate and its receptor NMDAR (69, 70).”
BackgroundSelf-citationA Role for ATF2 in Regulating MITF and Melanoma Development
Shah, M., Bhoumik, A., Goel, V., Dewing, A., Breitwieser, W., Kluger, H., Krajewski, S., Krajewska, M., DeHart, J., Lau, E., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001258 · Cited by 81 · cited 1×
“Another study functionally implicated upregulation of the developmental TF ATF2, whose characteristic expression in mouse and human melanomas indirectly suppresses MITF1, concomitant with malignant progression of the consequently dedifferentiated melanoma cells (10).”
BackgroundYu, X., Qiu, W., Yang, L., Zhang, Y., He, M., Li, L., & Xu, C. (2019) · The EMBO Journal · doi:10.15252/embj.2018100164 · Cited by 81 · cited 1×
“Notably, the multistep differentiation pathway of islet progenitor cells into mature β cells has been thoroughly characterized (13).”
BackgroundSMAD4 Suppresses WNT-Driven Dedifferentiation and Oncogenesis in the Differentiated Gut Epithelium
Perekatt, A. O., Shah, P. P., Cheung, S., Jariwala, N., Wu, A., Gandhi, V., Kumar, N., Feng, Q., Patel, N., Chen, L., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0043 · Cited by 80 · cited 1×
“SMAD4, by contrast, both enforces differentiation and thereby suppresses proliferation driven by oncogenic WNT signaling, revealed by the engineered loss of SMAD4 expression, providing an explanation for its loss of expression so as to enable dedifferentiation and, subsequently, WNT-driven hyperproliferation (5).”
BackgroundSunitinib facilitates metastatic breast cancer spreading by inducing endothelial cell senescence
Wang, D., Xiao, F., Feng, Z., Li, M., Kong, L., Huang, L., Wei, Y., Li, H., Liu, F., Zhang, H., et al. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01346-y · Cited by 74 · cited 1×
“For example, therapy-induced senescent tumor endothelial cells can enhance proliferation, invasion, and metastasis in breast cancer models (124, 125).”
BackgroundCellular Plasticity: A Route to Senescence Exit and Tumorigenesis
De Blander, H., Morel, A.-P., Senaratne, A. P., Ouzounova, M., & Puisieux, A. (2021) · Cancers · doi:10.3390/cancers13184561 · Cited by 72 · cited 3×
“Such transitory senescence is most well documented in cases of therapy resistance (44), representing a form of dormancy that circumvents therapeutic targeting of proliferating cancer cells, but may well prove to be more broadly operative in other stages of tumor development, malignant progression, and metastasis.”
BackgroundInfluentialByrd, A. L., Liu, M., Fujimura, K. E., Lyalina, S., Nagarkar, D. R., Charbit, B., Bergstedt, J., Patin, E., Harrison, O. J., Quintana-Murci, L., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20200606 · Cited by 63 · cited 1×
“There are evidently organ/tissue-specific differences in the constitution of the associated microbiomes in homeostasis, aging, and cancer, with both overlapping and distinctive species and abundancies to that of the colon (104, 105).”
BackgroundCancer Cells Retrace a Stepwise Differentiation Program during Malignant Progression
Saghafinia, S., Homicskó, K., Domenico, A. D., Wullschleger, S., Perren, A. A., Marinoni, I., Ciriello, G., Michael, I. P., & Hanahan, D. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1637 · Cited by 63 · cited 2×
“Additionally, a recent study (12) has associated lineage dedifferentiation with malignant progression from pancreatic islet cell neoplasias into metastasis-prone carcinomas; these neuroendocrine cells and derivative tumors arise from a developmental lineage that is distinct from the one generating the far larger numbe…”
BackgroundSelf-citation3D chromatin architecture and epigenetic regulation in cancer stem cells
Feng, Y., Liu, X., & Pauklin, S. (2021) · Protein & Cell · doi:10.1007/s13238-020-00819-2 · Cited by 62
Disruption of the RNA modifications that target the ribosome translation machinery in human cancer
Janin, M., Coll-SanMartin, L., & Esteller, M. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01192-8 · Cited by 60 · cited 3×
“Rather, upregulation of a miRNA previously implicated in specifying the islet progenitor state, one that is downregulated during terminal differentiation of β cells, has been shown to orchestrate the observed dedifferentiation occurring during malignant progression (12).”
BackgroundHow microbiota improve immunotherapy
Ansaldo, E., & Belkaid, Y. (2021) · Science · doi:10.1126/science.abl3656 · Cited by 54 · cited 1×
“These examples and others are beginning to chart the molecular mechanisms by which polymorphic microbiomes are indirectly and systemically modulating tumor immunobiology, above and beyond immune responses consequent to direct physical interactions of bacteria with the immune system (101, 102).”
BackgroundVaginal microbiomes and ovarian cancer: a review.
Xu, J., Peng, J.-J., Yang, W., Fu, K., & Zhang, Y. (2020) · PubMed Central · Cited by 52
Jiang, M., Azevedo-Pouly, A. C., Deering, T. G., Hoang, C. Q., DiRenzo, D., Hess, D. A., Konieczny, S. F., Swift, G. H., & MacDonald, R. J. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00370-16 · Cited by 49 · cited 1×
“maintenance of the differentiated pancreatic acinar cell state (25).”
BackgroundPrevention and Reversion of Pancreatic Tumorigenesis through a Differentiation-Based Mechanism
Krah, N. M., Narayanan, S. M., Yugawa, D. E., Straley, J. A., Wright, C. V. E., MacDonald, R. J., & Murtaugh, L. C. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.07.012 · Cited by 46
Nuclear organization and regulation of the differentiated state
Bitman-Lotan, E., & Orian, A. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03731-4 · Cited by 35
Extraordinary Cancer Epigenomics: Thinking Outside the Classical Coding and Promoter Box
Murtha, M. J., & Esteller, M. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.08.004 · Cited by 31
Stemming Colorectal Cancer Growth and Metastasis: HOXA5 Forces Cancer Stem Cells to Differentiate
Tan, S. H., & Barker, N. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.11.004 · Cited by 29 · cited 2×
“A variation on this theme involves another form of acute myeloid leukemia, this one carrying the t(8;21) translocation, which produces the AML1–ETO fusion protein.”
BackgroundTumors smother their epigenome
Thienpont, B., Dyck, L. V., & Lambrechts, D. (2016) · Molecular & Cellular Oncology · doi:10.1080/23723556.2016.1240549 · Cited by 28 · cited 1×
“Hypoxia, for example, reduces the activity of the TET demethylases, resulting in substantive changes in the methylome, in particular hypermethylation (58).”
BackgroundHegde, A. N., & Smith, S. G. (2019) · Learning & Memory · doi:10.1101/lm.048769.118 · Cited by 27 · cited 1×
“In the adult, for example, long-term memory involves changes in gene and histone modification, in chromatin structure, and in the triggering of gene expression switches that are stably maintained over time by positive and negative feedback loops (56, 57).”
BackgroundA Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis
Claps, G., Chéli, Y., Zhang, T., Scortegagna, M., Lau, E. K., Kim, H., Qi, J., Li, J., James, B. P., Dzung, A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.072 · Cited by 20 · cited 1×
“Conversely, expression in melanomas of mutant forms of ATF2 that fail to repress MITF results in well-differentiated melanomas (11).”
BackgroundStudying Lineage Plasticity One Cell at a Time
Drapkin, B. J., & Minna, J. D. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.07.001 · Cited by 10 · cited 1×
“Regulatory determinants of this dynamic phenotypic plasticity are beginning to be identified (37, 39, 40).”
BackgroundUnderstanding the Deadly Silence of Posterior Fossa A Ependymoma
Lin, G. L., & Monje, M. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.020 · Cited by 7 · cited 1×
“Rather, the aberrant growth of these cancer cells is demonstrably governed by a gene regulatory program induced by hypoxia (60, 61).”
Background(2001) · PubMed
Cited by
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
de Visser, K. E., & Joyce, J. A. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.016 · Cited by 4,059
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,047
Immune checkpoint therapy—current perspectives and future directions
Sharma, P., Goswami, S., Raychaudhuri, D., Siddiqui, B. A., Singh, P., Nagarajan, A., Liu, J., Subudhi, S. K., Poon, C., Gant, K. L., et al. (2023) · Cell · doi:10.1016/j.cell.2023.03.006 · Cited by 1,206
Exploring treatment options in cancer: tumor treatment strategies
Liu, B., Zhou, H., Tan, L., Siu, K. T. H., & Guan, X.-Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01856-7 · Cited by 1,201
Targeting HER2-positive breast cancer: advances and future directions
Swain, S. M., Shastry, M., & Hamilton, E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00579-0 · Cited by 1,160
Metadata
- Authors
- Hanahan, D.
- Affiliations
- Ludwig Cancer Research (CH)
- Corresponding author
- Hanahan, Douglas
- Venue
- Cancer Discovery
- Published
- 2022-01-01
- Volume
- 12
- Issue
- 1
- Pages
- 31-46
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- OpenAlex
- W4206662285
- Cited by
- 9,887
- References
- 129
- Citations by year
- 2026: 1979 · 2025: 2329 · 2024: 2526 · 2023: 2033 · 2022: 1015
- FWCI
- 243.80
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- cc-by-nc-nd
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- cancer hallmarks, phenotypic plasticity, epigenetic reprogramming, tumor microbiome, senescence-associated secretory phenotype, tumor microenvironment, tumor progression, carcinogenesis
- MeSH terms
- Humans, Neoplasms, Epigenomics, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.